Helsinn Group and Eisai Inc. to start Phase III for prevention of CINV

26 September 2011

Helsinn Therapeutics Initiates Global Pivotal Phase III Clinical Program to Evaluate Anamorelin in Non-Small Cell Lung Cancer-Associated Anorexia/Cachexia

20 September 2011

Cerbios confirmed by D&B in the top 500 Swiss companies with Risk Indicator 1

6 September 2011

Cerbios founder and former president, received an honorary doctorate from St. Petersburg’s Society of Oncologists

18 May 2011

Helsinn Group Invests in Thorne Research

12 May 2011

mondoBIOTECH holding AG (SIX:RARE): Presenting at BIO-Europe Spring 2011 on March 16, 2011

14 March 2011

Cerbios’ HPAI manufacturing facility P5 meets control performance within SafeBridge’s® Category 4

17 December 2010

Cerbios obtains Air Cargo Security Known Consignor Certification/2009

25 November 2010

Cerbios Pharma successfully passes a general GMP inspection

1 October 2010

APR Applied Pharma Research SA – LABORATORIOS CINFA

24 September 2010